These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 26673168)
1. Comparative transcriptomics reveals similarities and differences between astrocytoma grades. Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168 [TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV. Narsia N; Ramagiri P; Ehrmann J; Kolar Z Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381 [TBL] [Abstract][Full Text] [Related]
3. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Reuss DE; Kratz A; Sahm F; Capper D; Schrimpf D; Koelsche C; Hovestadt V; Bewerunge-Hudler M; Jones DT; Schittenhelm J; Mittelbronn M; Rushing E; Simon M; Westphal M; Unterberg A; Platten M; Paulus W; Reifenberger G; Tonn JC; Aldape K; Pfister SM; Korshunov A; Weller M; Herold-Mende C; Wick W; Brandner S; von Deimling A Acta Neuropathol; 2015 Sep; 130(3):407-17. PubMed ID: 26087904 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas. Wang C; Funk CC; Eddy JA; Price ND PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196 [TBL] [Abstract][Full Text] [Related]
6. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival. Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010 [TBL] [Abstract][Full Text] [Related]
7. Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition. Aiello KA; Alter O PLoS One; 2016; 11(10):e0164546. PubMed ID: 27798635 [TBL] [Abstract][Full Text] [Related]
8. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades. Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883 [TBL] [Abstract][Full Text] [Related]
10. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Marie SK; Okamoto OK; Uno M; Hasegawa AP; Oba-Shinjo SM; Cohen T; Camargo AA; Kosoy A; Carlotti CG; Toledo S; Moreira-Filho CA; Zago MA; Simpson AJ; Caballero OL Int J Cancer; 2008 Feb; 122(4):807-15. PubMed ID: 17960622 [TBL] [Abstract][Full Text] [Related]
11. [OMICS and biomarkers of glial tumors]. Idbaih A Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780 [TBL] [Abstract][Full Text] [Related]
12. Activation of EGFR signaling from pilocytic astrocytomas to glioblastomas. Carvalho PO; Uno M; Oba-Shinjo SM; Rosemberg S; Wakamatsu A; da Silva CC; Teixeira MJ; Marie SK Int J Biol Markers; 2014 Jun; 29(2):e120-8. PubMed ID: 24170555 [TBL] [Abstract][Full Text] [Related]
13. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127 [TBL] [Abstract][Full Text] [Related]
14. A systemic insight into astrocytoma biology across different grades. Chakraborty S; Ghosh Z J Cell Physiol; 2019 Apr; 234(4):4243-4255. PubMed ID: 30146735 [TBL] [Abstract][Full Text] [Related]
15. Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403 [TBL] [Abstract][Full Text] [Related]
16. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma. Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837 [TBL] [Abstract][Full Text] [Related]
18. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830 [TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]